Search - tctmd.com

Displaying 221 - 240 of 1163

Sort: Relevancy | Date

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

Sotatercept in Contemporary PAH Treatment Algorithm

Presenter: Thomas Cascino

February 12, 2025

Presentation THT 2025

Valvular Interventions in a Patient With Severe PH

Presenter: Estefania Oliveros

February 12, 2025

Presentation THT 2025

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

Presenter: Sebastian Roschx

February 12, 2025

Presentation THT 2025

HFpEF Hidden in Plain Sight: Undertreatment of Patients With Negative Screening for Suspected Amyloidosis

Presenter: Solenn Dal Soglio

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

Presenter: G. Michael Felker

February 12, 2025

Presentation THT 2025

Are We a Step Closer to 'Curing' PH?: Top 5 Lessons Learnt From the 7th World Symposia

Presenter: Raymond Benza

February 12, 2025

Presentation THT 2025

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 12, 2025

Presentation THT 2025

Pulmonary Artery Denervation for PH: Ready for Primetime?

Presenter: Greg Lewis

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

PA Counter-Pulsation

Presenter: Jane Leopold

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT 2025

When and Why Are Diuretics Sometimes Just Not Enough?

Presenter: Jennifer Cowger

February 12, 2025

Presentation THT 2025

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Presenter: Richa Gupta

February 11, 2025

Presentation THT 2025

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Presenter: Patrick McCann

February 11, 2025

Presentation THT 2025

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

Presenter: JoAnn Lindenfeld

February 11, 2025

Presentation THT 2025

What Lessons Can We Learn from DanGer in the Management of HF-CS

Presenter: Jacob Abraham

February 11, 2025

Presentation THT 2025

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Presenter: Kamran Muhammad

February 11, 2025

Advertisement

Inflammation as a Target in Acute HF

Sotatercept in Contemporary PAH Treatment Algorithm

Valvular Interventions in a Patient With Severe PH

Pressure-Volume Loop Derived Left Ventricular Hypercontractility Is Associated With Reduced Long-Term Survival in Heart Failure With Preserved Ejection Fraction

HFpEF Hidden in Plain Sight: Undertreatment of Patients With Negative Screening for Suspected Amyloidosis

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

Are We a Step Closer to 'Curing' PH?: Top 5 Lessons Learnt From the 7th World Symposia

Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)

Pulmonary Artery Denervation for PH: Ready for Primetime?

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

PA Counter-Pulsation

Inflammation and HFpEF: Rationale for HERMES

When and Why Are Diuretics Sometimes Just Not Enough?

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

What Lessons Can We Learn from DanGer in the Management of HF-CS

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content